Prehospital appointment of ticagrelor in patients with myocardial infarction and ST segment elevation (abstract)

Cover Page

Cite item

Full Text

Abstract

Материал подготовлен А.Л.Комаровым (д-р мед. наук, вед. науч. сотр. лаб. атеротромбоза НИИ кардиологии ФГБУ РКНПК) и О.О.Шахматовой (канд. мед. наук, мл. науч. сотр. лаб. атеротромбоза НИИ кардиологии ФГБУ РКНПК) по статье Montalescot G, van't Hof AW, Lapostolle F et al. Prehospital ticagrelor in ST -segment elevation myocardial infarction. N Engl J Med 2014; 371: 1016-27

About the authors

A. L Komarov

НИИ кардиологии ФГБУ РКНПК

д-р мед. наук, вед. науч. сотр. лаб. атеротромбоза

O. O Shakhmatova

НИИ кардиологии ФГБУ РКНПК

канд. мед. наук, мл. науч. сотр. лаб. атеротромбоза

References

  1. Wallentin L, Becker R.C, Budaj A et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-57.
  2. Montalescot G, Wiviott S.D, Braunwald E et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double - blind, randomised controlled trial. Lancet 2009; 373: 723-31.
  3. Bhatt D.L, Lincoff A.M, Gibson C.M et al. Intravenous platelet blockade with cangrelor during PCI. N Engl J Med 2009; 361: 2330-41.
  4. Bhatt D.L, Stone G.W, Mahaffey K.W et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 2013; 368:1303-13.
  5. Montalescot G, Barragan P, Wittenberg O et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-903.
  6. Herrmann H.C, Lu J, Brodie B.R et al. Benefit of facilitated percutaneous coronary intervention in high - risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. JACC Cardiovasc Interv 2009; 2: 917-24.
  7. Van't Hof A.W, Ten Berg J, Heestermans T et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double - blind, randomised controlled trial. Lancet 2008; 372: 537-46.
  8. Stone G.W, Grines C.L, Cox D.A et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346: 957-66.
  9. Ellis S.G, Tendera M, de Belder M.A et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008; 358: 2205-17.
  10. Zeymer U, Arntz H.R, Mark B et al. Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol 2012; 101: 305-12.
  11. Bellemain-Appaix A, O'Connor S.A, Silvain J et al. Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta - analysis. JAMA 2012; 308: 2507-16 [Erratum, JAMA 2013; 309: 1461].
  12. Sabatine M.S, Cannon C.P, Gibson C.M et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 2005; 294: 1224-32.
  13. Storey R.F, Angiolillo D.J, Patil S.B et al. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy. J Am Coll Cardiol 2010; 56: 1456-62.
  14. Montalescot G, Bolognese L, Dudek D et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med 2013; 369: 999-1010.
  15. Gurbel P.A, Bliden K.P, Butler K et al. Randomized double - blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009; 120: 2577-85.
  16. Alexopoulos D, Xanthopoulou I, Gkizas V et al. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment - elevation myocardial infarction. Circ Cardiovasc Interv 2012; 5: 797-804.
  17. Montalescot G, Lassen J.F, Hamm C.W et al. Ambulance or incatheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double - blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study. Am Heart J 2013; 165: 515-22.
  18. Montalescot G, van 't Hof A.W, Lapostolle F et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med 2014; 371: 1016-27.
  19. Cohen M.V, Downey J.M. Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered. J Cardiovasc Pharmacol Ther 2014; 19: 179-90.
  20. Parodi G, Bellandi B, Xanthopoulou I et al. Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circ Cardiovasc Interv 2015; 8: e001593; doi: 10.1161/CIRCINTERVENTIONS. 114.001593
  21. Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003.
  22. Lindholm D, Varenhorst C, Cannon C.P et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J 2014; 35 (31): 2083-93; doi: 10.1093/eurheartj/ehu160
  23. Parodi G, Xanthopoulou I, Bellandi B et al. Ticagrelor crushed tablets administration in STEMI patients: the Mashed Or Just Integral Tablets of ticagrelOr (MOJITO) study. J Am Coll Cardiol 2015; 65 (5): 511-2; doi: 10.1016/j.jacc.2014.08.056

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies